People: PerkinElmer Inc (PKI)
31.66USD
23 May 2013
$-0.16 (-0.50%)
$31.82
$31.44
$31.82
$31.34
523,335
1,213,465
$35.86
$23.73
Corbett, James
Brief Biography
Mr. James Corbett is Senior Vice President, President - Diagnostics of PerkinElmer Inc., since February 2012. He joined the Company in November 2007 as President for the ViaCord business unit through the acquisition of ViaCell, Inc. and Mr. Corbett also served as Vice President and General Manager of the Americas for the Diagnostics business unit since November 2007. Prior to joining the Company, he held positions in Abbott Laboratories, BioChem Immunosystems, CADx Systems, and iCad. Mr. Corbett holds a Bachelor of Science degree in business from the University of Massachusetts.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Robert Friel |
10,832,600 |
Frank Wilson |
2,297,220 |
Daniel Marshak |
1,751,490 |
Joel Goldberg |
1,922,640 |
John Letcher |
1,035,460 |
James Corbett |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
